176 related articles for article (PubMed ID: 33049034)
1. A novel isoform of ATOH8 promotes the metastasis of breast cancer by regulating RhoC.
Xu M; Huang S; Dong X; Chen Y; Li M; Shi W; Wang G; Huang C; Wang Q; Liu Y; Sun P; Yang S; Xiang R; Chang A
J Mol Cell Biol; 2021 Apr; 13(1):59-71. PubMed ID: 33049034
[TBL] [Abstract][Full Text] [Related]
2. Loss of ATOH8 Increases Stem Cell Features of Hepatocellular Carcinoma Cells.
Song Y; Pan G; Chen L; Ma S; Zeng T; Man Chan TH; Li L; Lian Q; Chow R; Cai X; Li Y; Li Y; Liu M; Li Y; Zhu Y; Wong N; Yuan YF; Pei D; Guan XY
Gastroenterology; 2015 Oct; 149(4):1068-81.e5. PubMed ID: 26099525
[TBL] [Abstract][Full Text] [Related]
3. High expression of atonal homolog 8 predicts a poor clinical outcome in patients with colorectal cancer and contributes to tumor progression.
Ye M; He Y; Lin H; Yang S; Zhou Y; Zhou L; Zhong J; Lu G; Zheng J; Xue ZX; Cai ZZ
Oncol Rep; 2017 May; 37(5):2955-2963. PubMed ID: 28393252
[TBL] [Abstract][Full Text] [Related]
4. BHLHE40 confers a pro-survival and pro-metastatic phenotype to breast cancer cells by modulating HBEGF secretion.
Sethuraman A; Brown M; Krutilina R; Wu ZH; Seagroves TN; Pfeffer LM; Fan M
Breast Cancer Res; 2018 Oct; 20(1):117. PubMed ID: 30285805
[TBL] [Abstract][Full Text] [Related]
5. RNF168 promotes RHOC degradation by ubiquitination to restrain gastric cancer progression via decreasing HDAC1 expression.
Xu Y; Feng Y; Sun Z; Li Q
Biochem Biophys Res Commun; 2021 Jun; 557():135-142. PubMed ID: 33865221
[TBL] [Abstract][Full Text] [Related]
6. Synergistic inhibition of aggressive breast cancer cell migration and invasion by cytoplasmic delivery of anti-RhoC silencing RNA and presentation of EPPT1 peptide on "smart" particles.
Kaushal N; Tiruchinapally G; Durmaz YY; Bao L; Gilani R; Merajver SD; ElSayed MEH
J Control Release; 2018 Nov; 289():79-93. PubMed ID: 30149048
[TBL] [Abstract][Full Text] [Related]
7. RhoC impacts the metastatic potential and abundance of breast cancer stem cells.
Rosenthal DT; Zhang J; Bao L; Zhu L; Wu Z; Toy K; Kleer CG; Merajver SD
PLoS One; 2012; 7(7):e40979. PubMed ID: 22911725
[TBL] [Abstract][Full Text] [Related]
8. HIF-3α Promotes Metastatic Phenotypes in Pancreatic Cancer by Transcriptional Regulation of the RhoC-ROCK1 Signaling Pathway.
Zhou X; Guo X; Chen M; Xie C; Jiang J
Mol Cancer Res; 2018 Jan; 16(1):124-134. PubMed ID: 28928287
[TBL] [Abstract][Full Text] [Related]
9. p38γ promotes breast cancer cell motility and metastasis through regulation of RhoC GTPase, cytoskeletal architecture, and a novel leading edge behavior.
Rosenthal DT; Iyer H; Escudero S; Bao L; Wu Z; Ventura AC; Kleer CG; Arruda EM; Garikipati K; Merajver SD
Cancer Res; 2011 Oct; 71(20):6338-49. PubMed ID: 21862636
[TBL] [Abstract][Full Text] [Related]
10. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer.
Ma L; Teruya-Feldstein J; Weinberg RA
Nature; 2007 Oct; 449(7163):682-8. PubMed ID: 17898713
[TBL] [Abstract][Full Text] [Related]
11. Shear stress activates ATOH8 via autocrine VEGF promoting glycolysis dependent-survival of colorectal cancer cells in the circulation.
Huang Q; Li S; Hu X; Sun M; Wu Q; Dai H; Tan Y; Sun F; Wang C; Rong X; Liao W; Peng J; Xiao J; Huang L; Wang J; Liang B; Lin K; Liu Y; Shi M
J Exp Clin Cancer Res; 2020 Jan; 39(1):25. PubMed ID: 32000836
[TBL] [Abstract][Full Text] [Related]
12. "Smart" Nanoparticles Enhance the Cytoplasmic Delivery of Anti-RhoC Silencing RNA and Inhibit the Migration and Invasion of Aggressive Breast Cancer Cells.
Kaushal N; Durmaz YY; Bao L; Merajver SD; ElSayed ME
Mol Pharm; 2015 Jul; 12(7):2406-17. PubMed ID: 26020100
[TBL] [Abstract][Full Text] [Related]
13. Integrin α3β1 can function to promote spontaneous metastasis and lung colonization of invasive breast carcinoma.
Zhou B; Gibson-Corley KN; Herndon ME; Sun Y; Gustafson-Wagner E; Teoh-Fitzgerald M; Domann FE; Henry MD; Stipp CS
Mol Cancer Res; 2014 Jan; 12(1):143-154. PubMed ID: 24002891
[TBL] [Abstract][Full Text] [Related]
14. The SmgGDS splice variant SmgGDS-558 is a key promoter of tumor growth and RhoA signaling in breast cancer.
Hauser AD; Bergom C; Schuld NJ; Chen X; Lorimer EL; Huang J; Mackinnon AC; Williams CL
Mol Cancer Res; 2014 Jan; 12(1):130-42. PubMed ID: 24197117
[TBL] [Abstract][Full Text] [Related]
15. Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer.
Chang XZ; Li DQ; Hou YF; Wu J; Lu JS; Di GH; Jin W; Ou ZL; Shen ZZ; Shao ZM
Breast Cancer Res; 2007; 9(6):R76. PubMed ID: 17980029
[TBL] [Abstract][Full Text] [Related]
16. RhoC: a fascinating journey from a cytoskeletal organizer to a Cancer stem cell therapeutic target.
Thomas P; Pranatharthi A; Ross C; Srivastava S
J Exp Clin Cancer Res; 2019 Jul; 38(1):328. PubMed ID: 31340863
[TBL] [Abstract][Full Text] [Related]
17. A definitive role of RhoC in metastasis of orthotopic lung cancer in mice.
Ikoma T; Takahashi T; Nagano S; Li YM; Ohno Y; Ando K; Fujiwara T; Fujiwara H; Kosai K
Clin Cancer Res; 2004 Feb; 10(3):1192-200. PubMed ID: 14871999
[TBL] [Abstract][Full Text] [Related]
18. Myosin-interacting guanine exchange factor (MyoGEF) regulates the invasion activity of MDA-MB-231 breast cancer cells through activation of RhoA and RhoC.
Wu D; Asiedu M; Wei Q
Oncogene; 2009 Jun; 28(22):2219-30. PubMed ID: 19421144
[TBL] [Abstract][Full Text] [Related]
19. Gasdermin-B promotes invasion and metastasis in breast cancer cells.
Hergueta-Redondo M; Sarrió D; Molina-Crespo Á; Megias D; Mota A; Rojo-Sebastian A; García-Sanz P; Morales S; Abril S; Cano A; Peinado H; Moreno-Bueno G
PLoS One; 2014; 9(3):e90099. PubMed ID: 24675552
[TBL] [Abstract][Full Text] [Related]
20. ITGA6 is directly regulated by hypoxia-inducible factors and enriches for cancer stem cell activity and invasion in metastatic breast cancer models.
Brooks DL; Schwab LP; Krutilina R; Parke DN; Sethuraman A; Hoogewijs D; Schörg A; Gotwald L; Fan M; Wenger RH; Seagroves TN
Mol Cancer; 2016 Mar; 15():26. PubMed ID: 27001172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
